Cargando…
Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma
A 70‐year‐old woman who was diagnosed with multiple myeloma underwent chemotherapy. Three months after beginning chemotherapy, she was readmitted to the hospital because of fever and hepatopathy. Her elevated Epstein–Barr virus (EBV) antibody levels showed that the hepatopathy was caused by reactiva...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014894/ https://www.ncbi.nlm.nih.gov/pubmed/24843446 http://dx.doi.org/10.1111/j.2040-1124.2010.00061.x |
_version_ | 1782315252784824320 |
---|---|
author | Fujiya, Atsushi Ochiai, Hiroshi Mizukoshi, Toshihiro Kiyota, Atsushi Shibata, Taiga Suzuki, Atsushi Ohashi, Norimi Sobajima, Hiroshi |
author_facet | Fujiya, Atsushi Ochiai, Hiroshi Mizukoshi, Toshihiro Kiyota, Atsushi Shibata, Taiga Suzuki, Atsushi Ohashi, Norimi Sobajima, Hiroshi |
author_sort | Fujiya, Atsushi |
collection | PubMed |
description | A 70‐year‐old woman who was diagnosed with multiple myeloma underwent chemotherapy. Three months after beginning chemotherapy, she was readmitted to the hospital because of fever and hepatopathy. Her elevated Epstein–Barr virus (EBV) antibody levels showed that the hepatopathy was caused by reactivation of EBV. On the 18th hospital day, the levels of fasting plasma glucose (FPG; 451 mg/dL) and pancreatic enzymes were suddenly elevated. Elevation of HbA(1c) level (6.4%) was slight, as compared with that of the FPG level. Arterial blood gas analysis showed metabolic acidosis and diabetic ketoacidosis was suspected. The serum C‐peptide level was below the detectable limit both before and after glucagon load, thereby suggesting an insulin‐dependent state. These features were identical to the features for fulminant type 1 diabetes mellitus. The levels of EBV anti‐viral capsid antigen immunoglobulin M decreased, and the clinical course was identical to that associated with reactivation of EBV infection. (J Diabetes Invest, doi: 10.1111/j.2040.1124.2010.00061.x, 2010) |
format | Online Article Text |
id | pubmed-4014894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40148942014-05-19 Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma Fujiya, Atsushi Ochiai, Hiroshi Mizukoshi, Toshihiro Kiyota, Atsushi Shibata, Taiga Suzuki, Atsushi Ohashi, Norimi Sobajima, Hiroshi J Diabetes Investig Articles A 70‐year‐old woman who was diagnosed with multiple myeloma underwent chemotherapy. Three months after beginning chemotherapy, she was readmitted to the hospital because of fever and hepatopathy. Her elevated Epstein–Barr virus (EBV) antibody levels showed that the hepatopathy was caused by reactivation of EBV. On the 18th hospital day, the levels of fasting plasma glucose (FPG; 451 mg/dL) and pancreatic enzymes were suddenly elevated. Elevation of HbA(1c) level (6.4%) was slight, as compared with that of the FPG level. Arterial blood gas analysis showed metabolic acidosis and diabetic ketoacidosis was suspected. The serum C‐peptide level was below the detectable limit both before and after glucagon load, thereby suggesting an insulin‐dependent state. These features were identical to the features for fulminant type 1 diabetes mellitus. The levels of EBV anti‐viral capsid antigen immunoglobulin M decreased, and the clinical course was identical to that associated with reactivation of EBV infection. (J Diabetes Invest, doi: 10.1111/j.2040.1124.2010.00061.x, 2010) Blackwell Publishing Ltd 2010-09-14 2010-12-03 /pmc/articles/PMC4014894/ /pubmed/24843446 http://dx.doi.org/10.1111/j.2040-1124.2010.00061.x Text en © 2010 Asian Association for the Study of Diabetes and Blackwell Publishing Asia Pty Ltd |
spellingShingle | Articles Fujiya, Atsushi Ochiai, Hiroshi Mizukoshi, Toshihiro Kiyota, Atsushi Shibata, Taiga Suzuki, Atsushi Ohashi, Norimi Sobajima, Hiroshi Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma |
title | Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma |
title_full | Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma |
title_fullStr | Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma |
title_full_unstemmed | Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma |
title_short | Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma |
title_sort | fulminant type 1 diabetes mellitus associated with a reactivation of epstein–barr virus that developed in the course of chemotherapy of multiple myeloma |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014894/ https://www.ncbi.nlm.nih.gov/pubmed/24843446 http://dx.doi.org/10.1111/j.2040-1124.2010.00061.x |
work_keys_str_mv | AT fujiyaatsushi fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma AT ochiaihiroshi fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma AT mizukoshitoshihiro fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma AT kiyotaatsushi fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma AT shibatataiga fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma AT suzukiatsushi fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma AT ohashinorimi fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma AT sobajimahiroshi fulminanttype1diabetesmellitusassociatedwithareactivationofepsteinbarrvirusthatdevelopedinthecourseofchemotherapyofmultiplemyeloma |